Ovid Therapeutics (OVID) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to $256000.0.
- Ovid Therapeutics' Accumulated Depreciation & Amortization fell 4348.79% to $256000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $256000.0, marking a year-over-year decrease of 4348.79%. This contributed to the annual value of $613000.0 for FY2024, which is 792.25% up from last year.
- Ovid Therapeutics' Accumulated Depreciation & Amortization amounted to $256000.0 in Q3 2025, which was down 4348.79% from $240000.0 recorded in Q2 2025.
- Ovid Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $613000.0 for Q4 2024, and its period low was $73807.0 during Q1 2022.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $240000.0 (2025), whereas its average is $283214.7.
- Within the past 5 years, the most significant YoY rise in Ovid Therapeutics' Accumulated Depreciation & Amortization was 11617.48% (2022), while the steepest drop was 6381.66% (2022).
- Ovid Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $237079.0 in 2021, then surged by 116.17% to $512505.0 in 2022, then increased by 10.83% to $568000.0 in 2023, then rose by 7.92% to $613000.0 in 2024, then crashed by 58.24% to $256000.0 in 2025.
- Its last three reported values are $256000.0 in Q3 2025, $240000.0 for Q2 2025, and $141000.0 during Q1 2025.